- New drug development and clinical trial
-
Chee DH
- KMID: 2188366
- J Korean Med Assoc.
- 2010 Sep;53(9):753-760.
- doi: 10.5124/jkma.2010.53.9.753
Drug development is a lengthy, expensive, and complex process, and clinical development is the longest and the most expensive stage of drug development. To obtain market authorization of a new... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Approval Process for Nonprescription Drugs in Different Countries
-
Kim JH, Yee J, Lee GY, Lee KE, Gwak HS
- KMID: 2437929
- Korean J Clin Pharm.
- 2018 Dec;28(4):263-272.
- doi: 10.24304/kjcp.2018.28.4.263
Nonprescription drugs have become increasingly important in Korean healthcare. By leveraging lower-cost drugs and reducing expenditure associated with fewer physician visits, the nonprescription segment can deliver tremendous value to individual... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of New Drug for Cognitive Enhancement of Schizophrenia: Introduction of Measurement And Treatment Research to Improve Cognition in Schizophrenia(MATRICS)
-
Lee SH, Jung HT, Chung YC
- KMID: 2286808
- Korean J Psychopharmacol.
- 2005 Jul;16(4):272-278.
Antipsychotic drugs have focused on treatment of positive and negative symptoms of schizophrenia. While these drugs resulted in improvements of these symptoms, they did not yield the expected recovery to... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
-
Ahn CH, Lim S
- KMID: 2449891
- J Stroke.
- 2019 May;21(2):139-150.
- doi: 10.5853/jos.2019.00038
Patients with hyperglycemia are at a high risk of cardio- and cerebrovascular diseases. Diabetes patients also have poor outcomes after cerebrovascular disease development. Several classes of drugs are used for... -
- CITED
-
- Close
- SHARE
-
- Close
- Current State and Future Improvement of the Elderly Participation in Clinical Trials
-
Kim SW, Jung HW, Park M, Chung JY, Lee KW, Kim JH, Lee JS, Kim KI, Kim CH
- KMID: 2340300
- J Korean Geriatr Soc.
- 2014 Sep;18(3):122-135.
- doi: 10.4235/jkgs.2014.18.3.122
BACKGROUND: Clinical trials are widely used to approve the efficacy and discover adverse reactions of new drugs. However, there has been much concern about the unjustified exclusion of the older... -
- CITED
-
- Close
- SHARE
-
- Close
